SCHEMBL7083547

SCHEMBL7083547

COC(=O)c1ccc(C2CCCc3ccccc32)cc1

nearest known ligand 0.64

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HAO1 Q9UJM8 1/20 0.64
MAPK1 P28482 1/20 0.59
MAPK14 Q16539 1/20 0.59
GID4 Q8IVV7 1/20 0.53
KMT2A Q03164 7/20 0.51
MEN1 O00255 4/20 0.51
MAPT P10636 1/20 0.51
HTT P42858 1/20 0.46
HNF4A P41235 1/20 0.46
TAOK1 Q7L7X3 1/20 0.46
TAOK3 Q9H2K8 1/20 0.46
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
LMNA P02545 1/20 0.45
NAMPT P43490 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20863587 0.86 HAO1 (0.57) HAO1MAPK1MAPK14GID4KMT2A
SCHEMBL8527467 0.85 HAO1 (0.64) HAO1MAPK1MAPK14GID4KMT2A
SCHEMBL2258847 0.84 IGF1R (0.53) HAO1MAPK1MAPK14GID4KMT2A
SCHEMBL11224194 0.83 HAO1 (0.77) HAO1MAPK1MAPK14GID4KMT2A
SCHEMBL14360065 0.82 HAO1 (0.64) HAO1MAPK1MAPK14GID4KMT2A
SCHEMBL13444088 0.79 GID4 (0.72) HAO1MAPK1MAPK14GID4KMT2A
SCHEMBL7324670 0.79 GID4 (0.72) HAO1MAPK1MAPK14GID4KMT2A
SCHEMBL11224856 0.78 HAO1 (1.00) HAO1MAPK1MAPK14KMT2AMEN1
Water SCHEMBL11227423 0.77 HAO1 (0.98) HAO1MAPK1MAPK14KMT2AMEN1
Water SCHEMBL11227425 0.77 HAO1 (0.98) HAO1MAPK1MAPK14KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1318978-A2 N-ACYLSULFONAMIDE APOPTOSIS PROMOTERS Abbott Laboratories (US) 2003-06-18 EP disclosed
WO-2002024636-A2 N-ACYLSULFONAMIDE APOPTOSIS PROMOTERS ABBOTT LABORATORIES (US) 2002-03-28 WO disclosed